Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials
- PMID: 29063592
- PMCID: PMC5916745
- DOI: 10.1111/jcpp.12830
Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials
Abstract
Background: Improvements in executive functioning (EF) may lead to improved quality of life and lessened functional impairment for children with mood disorders. The aim was to assess the impact of omega-3 supplementation (Ω3) and psychoeducational psychotherapy (PEP), each alone and in combination, on EF in youth with mood disorders. We completed secondary analyses of two randomized controlled trials (RCTs) of Ω3 and PEP for children with depression and bipolar disorder.
Methods: Ninety-five youths with depression or bipolar disorder not otherwise specified/cyclothymic disorder were randomized in 12-week RCTs. Two capsules (Ω3 or placebo) were given twice daily (1.87 g Ω3 total daily, mostly eicosapentaenoic acid). Families randomized to PEP participated in twice-weekly 50-min sessions. Analyses assess impact of interventions on the Behavior Rating Inventory of Executive Functioning (BRIEF) parent-report Global Executive Composite (GEC) and two subscales, Behavior Regulation (BRI) and Metacognition (MI) Indices. Intent-to-treat repeated measures ANOVAs, using multiple imputation for missing data, included all 95 randomized participants. Trials were registered with www.clinicaltrials.gov, NCT01341925 & NCT01507753.
Results: Participants receiving Ω3 (aggregating combined and monotherapy) improved significantly more than aggregated placebo on GEC (p = .001, d = .70), BRI (p = .004, d = .49), and MI (p = .04, d = .41). Ω3 alone (d = .49) and combined with PEP (d = .67) each surpassed placebo on GEC. Moderation by attention-deficit/hyperactivity disorder (ADHD) comorbidity was nonsignificant although those with ADHD showed nominally greater gains. PEP monotherapy had negligible effect.
Conclusions: Decreased impairment in EF was associated with Ω3 supplementation in youth with mood disorders. Research examining causal associations of Ω3, EF, and mood symptoms is warranted.
Keywords: School children; bipolar disorder; depression; nutrition; psychotherapy.
© 2017 Association for Child and Adolescent Mental Health.
Conflict of interest statement
Conflict of interest statement: See Acknowledgements for disclosures.
Figures
Comment in
-
Editorial: Can omega-3 fatty acids improve executive functioning? Will this reduce ADHD and depression?J Child Psychol Psychiatry. 2018 Jun;59(6):615-617. doi: 10.1111/jcpp.12932. J Child Psychol Psychiatry. 2018. PMID: 29808491
Similar articles
-
A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder.J Child Adolesc Psychopharmacol. 2015 Dec;25(10):764-74. doi: 10.1089/cap.2015.0132. J Child Adolesc Psychopharmacol. 2015. PMID: 26682997 Free PMC article. Clinical Trial.
-
Pilot Randomized Controlled Trial of Omega-3 and Individual-Family Psychoeducational Psychotherapy for Children and Adolescents With Depression.J Clin Child Adolesc Psychol. 2019;48(sup1):S105-S118. doi: 10.1080/15374416.2016.1233500. Epub 2016 Nov 7. J Clin Child Adolesc Psychol. 2019. PMID: 27819485 Free PMC article. Clinical Trial.
-
Psychoeducational Psychotherapy and Omega-3 Supplementation Improve Co-Occurring Behavioral Problems in Youth with Depression: Results from a Pilot RCT.J Abnorm Child Psychol. 2017 Jul;45(5):1025-1037. doi: 10.1007/s10802-016-0203-3. J Abnorm Child Psychol. 2017. PMID: 27604240 Free PMC article. Clinical Trial.
-
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3. Cochrane Database Syst Rev. 2023. PMID: 37058600 Free PMC article. Review.
-
EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.J Am Coll Nutr. 2009 Oct;28(5):525-42. doi: 10.1080/07315724.2009.10719785. J Am Coll Nutr. 2009. PMID: 20439549 Review.
Cited by
-
Omega-3 fatty acid supplementation for depression in children and adolescents.Cochrane Database Syst Rev. 2024 Nov 20;11(11):CD014803. doi: 10.1002/14651858.CD014803.pub2. Cochrane Database Syst Rev. 2024. PMID: 39564892 Review.
-
A Systematic Review of Psychobiotic Interventions in Children and Adolescents to Enhance Cognitive Functioning and Emotional Behavior.Nutrients. 2022 Jan 30;14(3):614. doi: 10.3390/nu14030614. Nutrients. 2022. PMID: 35276975 Free PMC article. Review.
-
Targeting Divergent Pathways in the Nutritional Management of Depression.Nutrients. 2024 Aug 22;16(16):2806. doi: 10.3390/nu16162806. Nutrients. 2024. PMID: 39203943 Free PMC article. Review.
-
Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.J Child Adolesc Psychopharmacol. 2020 Jun;30(5):293-305. doi: 10.1089/cap.2019.0124. Epub 2020 Mar 11. J Child Adolesc Psychopharmacol. 2020. PMID: 32167792 Free PMC article. Clinical Trial.
-
Executive functions and borderline personality features in adolescents with major depressive disorder.Front Hum Neurosci. 2023 Jun 22;17:957753. doi: 10.3389/fnhum.2023.957753. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37425294 Free PMC article.
References
-
- Babcock T, Helton WS, Espat NJ. Eicosapentaenoic acid (EPA): an antiinflammatory omega-3 fat with potential clinical applications. Nutrition. 2000;16(11–12):1116–1118. - PubMed
-
- Birmaher B. Longitudinal course of pediatric bipolar disorder. The American journal of psychiatry. 2007;164(4):537–539. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
